COVID‐19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision
Elena Sotiriou, Katerina Bakirtzi, Ilias Papadimitriou, Eleni Paschou, Efstratios Vakirlis, Aimilios Lallas, D. Ioannides
Abstract
Psoriasis (Ps) is a chronic, immune-mediated skin disease with systemic involvement. Therapeutic advancements in its management have considerably improved disease activity and quality of life, and reduced hospitalization rates. Nevertheless, prolonged immunosuppression in psoriatic patients may increase their susceptibility to opportunistic infections.
Topics & Concepts
PsoriasisImmunosuppressionMedicineVaccinationCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseImmune systemQuality of life (healthcare)DermatologyInternal medicineInfectious disease (medical specialty)NursingPsoriasis: Treatment and PathogenesisFibromyalgia and Chronic Fatigue Syndrome ResearchSpondyloarthritis Studies and Treatments